Back to BCLIView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Amyotrophic Lateral Sclerosis (ALS)
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
NurOwn (MSC-NTF cells)Phase 2
Multiple Sclerosis, Chronic Progressive
MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSFPhase 2
Amyotrophic Lateral Sclerosis
MSC-NTF cells transplantation (IM)Phase 2
Amyotrophic Lateral Sclerosis
Nurown MSC-NTF cellsPhase 2
Amyotrophic Lateral Sclerosis (ALS)
MSC-NTF cells transplantation (IT)Phase 2
Amyotrophic Lateral Sclerosis
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts